SynthesisESC heart failure2022

Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial.

Michele Senni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.